IMARC Group, a leading market research company, has recently releases report titled “Artificial Cornea and Corneal Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global artificial cornea and corneal implant market share, growth, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Artificial Cornea and Corneal Implant

Also known as the synthetic cornea, artificial cornea and corneal implants are prosthetic devices designed to replace the natural cornea in the human eye. It consists of a clear, dome-shaped surface that covers the front of the eye and helps focus light onto the retina. It is made of durable, biocompatible materials that offer a minimal risk of rejection by the immune system as compared to donor corneas. It corrects refractive errors and restores visual acuity in individuals with damaged and diseased corneas. As a result, it finds extensive applications in specialty clinics, hospitals, and ambulatory surgical centers.

How Big Is the Artificial Cornea and Corneal Implant Market?

The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Request Sample Copy of This Report: https://www.imarcgroup.com/artificial-cornea-corneal-implant-market/requestsample

What are the growth prospects and trends in the artificial cornea and corneal implant industry?

The growing geriatric population and the increasing prevalence of corneal infections and eye-associated disorders among the masses represent one of the key factors positively influencing the market across the globe.

In addition, the burgeoning healthcare sector and ongoing development of healthcare facilities, such as hospitals, nursing homes, and eye clinics, that facilitate effective treatment to patients are bolstering the growth of the market. Moreover, the rising occurrence of eyesight complications among young individuals due to prolonged hours of looking at smartphones and working on computers and laptops is contributing to the market growth.

Furthermore, shifting preferences towards minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays is stimulating the growth of the market worldwide.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Human Cornea
  • Artificial Cornea

Breakup by Transplant Type:

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Anterior Lamellar Keratoplasty
  • Keratoprosthesis

Breakup by Disease Indication:

  • Fuchs' Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Advancing Sight Network,  AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/